Antidepressant found to reduce COVID-19 hospitalizations: study
An affordable antidepressant has been found in a clinical trial to reduce the risk of hospitalization in high-risk adults with recently diagnosed COVID-19, according to a study published in The Lancet Global Health.
The drug, known as fluvoxamine, is a selective serotonin reuptake inhibitor (SSRI) commonly used in the treatment of depression, anxiety, obsessive-compulsive disorder and other mood disorders. Its low price makes it a desirable treatment option for less wealthy nations, the researchers wrote.
Researchers began looking into the drug during the height of the pandemic because of the antidepressant’s ability to reduce inflammation, according to The New York Times. The researchers thus hypothesized that the drug may allow the body to quell an overwhelming response to a COVID-19 infection.
Other studies have come out in the past months on fluvoxamine that also showed promising results; however, no study has been as large as the one published Wednesday, according to the Times.
Read Full Story
The Hill Rating
More Stories
Biden Expresses Strong Support For Finland, Sweden NATO Bids
U.S. President Joe Biden has strongly backed the bids of Finland and Sweden to join NATO in the face of...
U.S. COVID-19 cases increased threefold over past month
People queue to be tested for COVID-19 in Times Square, as the Omicron coronavirus variant continues to spread in Manhattan, New York City, U.S., December 20, 2021. REUTERS/Andrew Kelly/File PhotoRegister now for FREE unlimited access to Reuters.comWASHINGTON, May 18 (Reuters) – Health officials are considering extending the eligibility for a second COVID-19 vaccine booster dose…
Cancer drug may treat severe COVID-19, study finds
Imatinib may help patients hospitalized with severe COVID-19, according to a new study. Photo by Patrick Pelletier/Wikimedia Commons May 18 (UPI) — Patients with severe COVID-19 who received the cancer drug imatinib were less likely to die than those not treated with it, a study presented Wednesday found. Nine percent of patients hospitalized with the…
Schumer implores Fox News leaders to stop ‘amplification’ of ‘replacement theory’
Senate Majority Leader Charles Schumer (D-N.Y.) is demanding that ownership and executives at Fox News stop what he says is the “reckless...
Biden urges all Americans to reject ‘poison’ of white supremacy after Buffalo mass shooting
Joe Biden has called on all Americans to reject the "poison" of white supremacy following a "racially-motivated" mass shooting at...
Sweden Signs NATO Admission Request; Finnish Lawmakers Set To Formally Endorse Move
Sweden has signed a formal request to join NATO, a day after Stockholm announced it would seek membership in the...